AstraZeneca, Daiichi Sankyo breast cancer drug Trastuzumab Deruxtecan shows promise Medical Dialogues Bureau10 May 2019 9:00 AM ISTThe treatment Trastuzumab Deruxtecan, or DS-8201, demonstrated a clinically meaningful response in patients with refractory HER2-positive metastatic...
AstraZeneca Q1 sales beat estimates on cancer drugs Garima28 April 2019 9:15 AM ISTAstraZeneca, fresh off an oncology deal with Japan's Daiichi Sankyo Co Ltd, in February reported annual sales growth for the first time since 2009,...
AstraZeneca gets EU nod to diabetes drug Forxiga Medical Dialogues Bureau27 March 2019 2:55 PM ISTFarxiga or Forxiga, as the drug is known outside the United States, is one of AstraZeneca's top ten drugs by sales. It generated $1.39 billion in 2018...